s and cells. The Company is lead drug partner with Quark & Pfizer and is on Phase I for PKN3-targeted cancer siRNA. • Alnylam Pharmaceuticals Inc (ALNY US) — is an early stage therapeutics company. The Company is developing technology that can specifically and potently silence disease-causing genes. T